Coldstream Capital Management’s Arvinas ARVN Stock Holding History

Coldstream Capital Management’s Portfolio ARVN Stock Details ARVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-157	Closed	-$1.1K	–	1267
2025 Q1	$1.1K	Buy	+157	New	+$2.46K	﹤0.01%	3162

Other funds holding ARVN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Coldstream Capital Management's ARVN Position: Q2 2025 in Review

Coldstream Capital Management sold out of Arvinas (ARVN) in Q2 2025, closing a stake of 157 shares — an estimated $1.1K sold.

Coldstream Capital Management first reported a position in ARVN in Q1 2025 and held it in 1 quarter. The position peaked at $1.1K in Q1 2025. 215 funds tracked by Wall St. Rank hold ARVN as of Q2 2025.

Coldstream Capital Management reported no remaining Arvinas position as of Q2 2025 after selling out during the quarter.
Coldstream Capital Management sold 157 Arvinas shares in Q2 2025, an estimated $1.1K.
Coldstream Capital Management first reported a position in Arvinas in Q1 2025 and held it in 1 quarter.
Coldstream Capital Management's Arvinas position peaked at $1.1K in Q1 2025.
215 funds tracked by Wall St. Rank held Arvinas as of Q2 2025.

Based on Coldstream Capital Management's 13F filing for Q2 2025, filed 12 Aug 2025.